JP2022548902A5 - - Google Patents
Info
- Publication number
- JP2022548902A5 JP2022548902A5 JP2022517339A JP2022517339A JP2022548902A5 JP 2022548902 A5 JP2022548902 A5 JP 2022548902A5 JP 2022517339 A JP2022517339 A JP 2022517339A JP 2022517339 A JP2022517339 A JP 2022517339A JP 2022548902 A5 JP2022548902 A5 JP 2022548902A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cells
- expression construct
- scfv
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962902237P | 2019-09-18 | 2019-09-18 | |
| US62/902,237 | 2019-09-18 | ||
| PCT/US2020/050864 WO2021055349A1 (en) | 2019-09-18 | 2020-09-15 | A method of engineering natural killer-cells to target bcma-positive tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022548902A JP2022548902A (ja) | 2022-11-22 |
| JP2022548902A5 true JP2022548902A5 (cg-RX-API-DMAC7.html) | 2023-09-29 |
Family
ID=74883668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022517339A Pending JP2022548902A (ja) | 2019-09-18 | 2020-09-15 | Bcma陽性腫瘍を標的とするためのナチュラルキラー細胞の操作方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220370500A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4031577A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022548902A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114729046A (cg-RX-API-DMAC7.html) |
| AR (1) | AR119990A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202124447A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021055349A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11629340B2 (en) | 2017-03-03 | 2023-04-18 | Obsidian Therapeutics, Inc. | DHFR tunable protein regulation |
| JP7773789B2 (ja) | 2020-03-28 | 2025-11-20 | ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム | 癌の治療のための細胞免疫療法 |
| AU2022273049A1 (en) * | 2021-05-14 | 2024-01-04 | Board Of Regents, The University Of Texas System | Chimeric polypeptides and methods of use |
| CA3233096A1 (en) * | 2021-10-20 | 2023-04-17 | Board Of Regents, The University Of Texas System | Engineering nk cells with a car construct with optimal signaling |
| AU2022372894A1 (en) | 2021-10-20 | 2024-04-18 | Takeda Pharmaceutical Company Limited | Compositions targeting bcma and methods of use thereof |
| WO2023177954A1 (en) * | 2022-03-18 | 2023-09-21 | University Of Rochester | Combination therapy for treatment of cancer, methods and systems of delivery thereof |
| JP2026512487A (ja) * | 2023-04-18 | 2026-04-16 | ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム | Bcmaキメラ抗原受容体及びその使用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013246443B2 (en) * | 2012-04-11 | 2017-04-27 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Chimeric antigen receptors targeting B-cell maturation antigen |
| US10383929B2 (en) * | 2014-12-12 | 2019-08-20 | Bluebird Bio, Inc. | BCMA chimeric antigen receptors |
| TWI700298B (zh) * | 2015-04-13 | 2020-08-01 | 美商輝瑞股份有限公司 | 靶向b細胞成熟抗原之嵌合型抗原受體類 |
| TWI833684B (zh) * | 2015-06-25 | 2024-03-01 | 美商生物細胞基因治療有限公司 | 嵌合抗原受體(car)、組合物及其使用方法 |
| JP2020517259A (ja) * | 2017-04-19 | 2020-06-18 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | 操作された抗原受容体を発現する免疫細胞 |
| US11905528B2 (en) * | 2017-10-12 | 2024-02-20 | Icell Gene Therapeutics Inc. | Compound chimeric antigen receptor (cCAR) targeting multiple antigens, compositions and methods of use thereof |
| CN109468283A (zh) * | 2018-11-30 | 2019-03-15 | 北京美康基免生物科技有限公司 | 一种基于cd19和bcma的双重嵌合抗原受体基因修饰的免疫细胞及其应用 |
| CN109734814A (zh) * | 2019-02-12 | 2019-05-10 | 南京卡提医学科技有限公司 | 具有免疫受体的工程化t细胞治疗癌症的用途 |
-
2020
- 2020-09-15 JP JP2022517339A patent/JP2022548902A/ja active Pending
- 2020-09-15 CN CN202080079943.1A patent/CN114729046A/zh active Pending
- 2020-09-15 WO PCT/US2020/050864 patent/WO2021055349A1/en not_active Ceased
- 2020-09-15 EP EP20866895.4A patent/EP4031577A4/en not_active Withdrawn
- 2020-09-15 US US17/761,190 patent/US20220370500A1/en not_active Abandoned
- 2020-09-17 AR ARP200102578A patent/AR119990A1/es unknown
- 2020-09-18 TW TW109132239A patent/TW202124447A/zh unknown